Wendtner, C-M; Ritgen, M; Schweighofer, C D; Fingerle-Rowson, G; Campe, H; Jäger, G; Eichhorst, B; Busch, R; Diem, H; Engert, A. (2004). Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission – experience on safety and efficacy within a randomized multicenter phase III trial of the German CLL Study Group (GCLLSG). , 18(6), 1093–1101.
doi:10.1038/sj.leu.2403354
